Abstract:Abstract Early detection of Alzheimer’s disease is required to identify patients suitable for disease-modifying medications and to improve access to non-pharmacological preventative interventions. Prior research shows detectable changes in speech in Alzheimer’s dementia and its clinical precursors. The current study assesses whether a fully automated speech-based artificial intelligence system can detect cognitive impairment and amyloid beta positivity, which characterize early stages of Alzheimer’s disease. Two hundred participants (age 54–85, mean 70.6; 114 female, 86 male) from sister studies in the UK (NCT04828122) and the USA (NCT04928976), completed the same assessments and were combined in the current analyses. Participants were recruited from prior clinical trials where amyloid beta status (97 amyloid positive, 103 amyloid negative, as established via PET or CSF test) and clinical diagnostic status was known (94 cognitively unimpaired, 106 with mild cognitive impairment or mild Alzheimer’s disease). The automatic story recall task was administered during supervised in-person or telemedicine assessments, where participants were asked to recall stories immediately and after a brief delay. An artificial intelligence text-pair evaluation model produced vector-based outputs from the original story text and recorded and transcribed participant recalls, quantifying differences between them. Vector-based representations were fed into logistic regression models, trained with tournament leave-pair-out cross-validation analysis to predict amyloid beta status (primary endpoint), mild cognitive impairment and amyloid beta status in diagnostic subgroups (secondary endpoints). Predictions were assessed by the area under the receiver operating characteristic curve for the test result in comparison with reference standards (diagnostic and amyloid status). Simulation analysis evaluated two potential benefits of speech-based screening: (i) mild cognitive impairment screening in primary care compared with the Mini-Mental State Exam, and (ii) pre-screening prior to PET scanning when identifying an amyloid positive sample. Speech-based screening predicted amyloid beta positivity (area under the curve = 0.77) and mild cognitive impairment or mild Alzheimer’s disease (area under the curve = 0.83) in the full sample, and predicted amyloid beta in subsamples (mild cognitive impairment or mild Alzheimer’s disease: area under the curve = 0.82; cognitively unimpaired: area under the curve = 0.71). Simulation analyses indicated that in primary care, speech-based screening could modestly improve detection of mild cognitive impairment (+8.5%), while reducing false positives (−59.1%). Furthermore, speech-based amyloid pre-screening was estimated to reduce the number of PET scans required by 35.3% and 35.5% in individuals with mild cognitive impairment and cognitively unimpaired individuals, respectively. Speech-based assessment offers accessible and scalable screening for mild cognitive impairment and amyloid beta positivity.

Selecting and Analyzing Speech Features for the Screening of Mild Cognitive Impairment

Identification of Alzheimer's Disease Patients Based on Oral Speech Features

Automatic speech analysis for detecting cognitive decline of older adults

Screening for early Alzheimer's disease: enhancing diagnosis with linguistic features and biomarkers

Screening for early Alzheimer’s disease: enhancing diagnosis with linguistic features and biomarkers

Computer-Assisted Speech Analysis in Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study from Shanghai, China.

Detection of Mild Cognitive Impairment From Non-Semantic, Acoustic Voice Features: The Framingham Heart Study

A Comparison of Speech Features between Mild Cognitive Impairment and Healthy Aging Groups

Exploiting Longitudinal Speech Sessions via Voice Assistant Systems for Early Detection of Cognitive Decline

Automated assessment of speech production and prediction of MCI in older adults

Leveraging speech and artificial intelligence to screen for early Alzheimer’s disease and amyloid beta positivity

Shanghai Cognitive Screening: A Mobile Cognitive Assessment Tool Using Voice Recognition to Detect Mild Cognitive Impairment and Dementia in the Community.

P1‐349: Computer Assisted Speech Analysis in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease

Combining Speech and Drawing Data for Alzheimer's Disease Detecting

Dementia Detection by Analyzing Spontaneous Mandarin Speech.

Design and development of the intelligent voice recognition‐based cognitive assessment WeChat mini‐program

A Novel Detection Tool for Mild Cognitive Impairment Patients Based on Eye Movement and Electroencephalogram

Automated Classification of Cognitive Decline and Probable Alzheimer's Dementia Across Multiple Speech and Language Domains

ADscreen: A speech processing-based screening system for automatic identification of patients with Alzheimer's disease and related dementia

Multimodal fusion for alzheimer’s disease recognition

Exploring linguistic feature and model combination for speech recognition based automatic AD detection